The use of testosterone in brain dead patients who are candidates for organ donation in order to maintain and stabilize blood pressure

Phase 2

Recruiting

• Conditions: Other specified disorders of central nervous system; brain dead.; G96.8

• Registration Number: IRCT20130304012695N17
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Brain dead patients aged 18-60 years are candidates for organ donation

Exclusion Criteria

Patients who have high blood pressure and do not need inotropes
Hemodynamically unstable patients who will undergo organ donation surgery in less than 6 hours

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Dosage of noradrenaline. Timepoint: At the beginning of the patient's entry into the study and 8 hours after drug injection. Method of measurement: milliliters per hour.;Peripheral vascular resistance. Timepoint: At the beginning of the patient's entry into the study and 8 hours after drug injection. Method of measurement: By Ultrasonic Cardiac Output Monitor.

Secondary Outcome Measures

Name	Time	Method
Cardiac output. Timepoint: At the beginning of the patient's entry into the study and 8 hours after drug injection. Method of measurement: By Ultrasonic Cardiac Output Monitor.;Cardiac Index. Timepoint: At the beginning of the patient's entry into the study and 8 hours after drug injection. Method of measurement: By Ultrasonic Cardiac Output Monitor.